MetLife Investment Management, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$736,013
-23.4%
23,9900.0%0.01%
-14.3%
Q2 2023$961,279
-0.5%
23,990
+1.3%
0.01%0.0%
Q1 2023$966,013
+5.7%
23,6710.0%0.01%0.0%
Q4 2022$913,937
-27.4%
23,6710.0%0.01%
-36.4%
Q3 2022$1,259,060
-8.8%
23,6710.0%0.01%0.0%
Q2 2022$1,380,019
-23.6%
23,6710.0%0.01%
-8.3%
Q1 2022$1,806,571
+96.9%
23,671
+55.3%
0.01%
+50.0%
Q4 2021$917,352
+7.4%
15,2460.0%0.01%0.0%
Q3 2021$853,776
-16.0%
15,246
-9.0%
0.01%
-20.0%
Q2 2021$1,016,754
-13.4%
16,7560.0%0.01%
-9.1%
Q1 2021$1,174,428
+6.0%
16,756
-9.5%
0.01%0.0%
Q4 2020$1,107,459
-0.5%
18,5070.0%0.01%
-8.3%
Q3 2020$1,112,641
+14.6%
18,5070.0%0.01%
+9.1%
Q2 2020$971,062
+56.5%
18,5070.0%0.01%
+22.2%
Q1 2020$620,540
-26.0%
18,5070.0%0.01%0.0%
Q4 2019$838,367
+19.0%
18,5070.0%0.01%
+12.5%
Q3 2019$704,561
-12.5%
18,5070.0%0.01%
-11.1%
Q2 2019$804,869
+14.3%
18,5070.0%0.01%
+12.5%
Q1 2019$704,376
-11.5%
18,5070.0%0.01%
-20.0%
Q4 2018$796,171
-12.5%
18,5070.0%0.01%0.0%
Q3 2018$909,619
+53.4%
18,5070.0%0.01%
+42.9%
Q2 2018$593,000
+3.0%
18,5070.0%0.01%0.0%
Q1 2018$576,000
-31.8%
18,5070.0%0.01%
-30.0%
Q4 2017$845,00018,5070.01%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Tamarack Advisers, LP 360,000$21,845,0006.19%
Gagnon Advisors, LLC 213,217$12,938,0004.92%
GAGNON SECURITIES LLC 499,333$30,300,0004.30%
Spyglass Capital Management LLC 2,117,673$128,500,0002.86%
NEUMEIER POMA INVESTMENT COUNSEL LLC 646,530$39,231,0002.30%
Paulson & Co. 1,273,161$77,255,0001.85%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 212,112$12,871,0001.44%
Tygh Capital Management, Inc. 152,332$9,244,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,147,000$69,600,0001.24%
Rock Springs Capital Management LP 1,025,000$62,197,0001.23%
View complete list of PACIRA PHARMACEUTICALS INC shareholders